Researchers developed and evaluated a deep learning model for predicting coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS).
For biotechs in the industry’s handful of hot areas, it’s a seller’s market
A radiopharma company purchased for more than three times the price of its IPO from a few months earlier. Neuroscience companies driving up their offers